US research institute to create new campus on the Oxford Science Park

Lawrence J. Ellison Institute for Transformative Medicine, a US research organisation, is to create a new campus to build collaborations across the Oxford life science ecosystem

Leading US-based research organisation, the Lawrence J.Ellison Institute for Transformative Medicine, is significantly expanding its commitment to Oxford by establishing a major presence at The Oxford Science Park (TOSP), one of Europe’s leading locations for science and technology companies.

To facilitate the development of the Ellison Institute’s new Oxford campus, TOSP has agreed to sell a 150-year lease on a 3.5  acre site in the Park. This will connect directly with the adjacent 5.9-acre Littlemore House site that the Ellison Institute acquired in December 2021, creating a major presence in Oxford. The Ellison Institute’s Oxford campus will provide a permanent home to research laboratories, a patient clinic, offices, and collaborative spaces supporting Ellison Institute projects, including the Global Health Security Consortium’s work on pandemic preparedness. The development will enable the Ellison Institute to collaborate extensively with companies and organisations across the Park, as well as the wider Oxford innovation ecosystem. The new location also enables the Ellison Institute to expand its existing partnership with Oxford Nanopore Technologies, one of the major international companies based at the Park.

Rory Maw, CEO of The Oxford Science Park, said, ‘We’re delighted to welcome the Ellison Institute to the Park and look forward to working with the team to help deliver their vision for the new Oxford campus. This commitment will reinforce the ground-breaking research and development already taking place on the Park, delivering benefits and opportunities for our occupiers and the wider Oxford innovation ecosystem.’

 

Dinah Rose QC, President of Magdalen College, said, “Following closely on from our strategic partnership with GIC, the Singapore sovereign wealth fund, this is an exciting next step in the evolution of the Park. We look forward to developing a close long-term relationship with the Ellison Institute and to enhancing further Oxford’s enormous contribution to addressing global health challenges.’

 

‘We look forward to continuing the development of our Oxford presence and partnerships,’ said Dr David Agus, founding director and CEO of the Ellison Institute. ‘These acquisitions give us greater capacity to undertake critical biomedical research as well as the educational initiatives of the Institute in collaboration with Oxford University.

Recent news

Nebula’s sustainable timber beams rise out of the ground

Nebula’s sustainable timber beams rise out of the ground

Drone footage at Milton Park shows construction is well underway on Nebula, a £40m research and development (R&D) scheme.   Following a ground-breaking ceremony with Science Minister Andrew Griffith MP earlier in the year, a drone fly-through shows one of the...

read more
Oxford to Cambridge SIT Premises Business Survey

Oxford to Cambridge SIT Premises Business Survey

The Oxford to Cambridge pan-Regional Partnership (OCPRP) invites you to participate in an important survey aimed at understanding the needs and preferences of businesses within the Science, Innovation, and Technology (SIT) sectors across the Oxford to Cambridge...

read more
Oxford North tops out and unveils new park name

Oxford North tops out and unveils new park name

Oxford North, the new innovation district in Oxford, has reached its highest point in construction and topped out its first phase with the Red Hall’s new cantilever roof lowered into place, and two new lab buildings' steel frames completed.   Oxford North is the...

read more
Loading...